Compass Therapeutics, Inc. (CMPX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $25.0K | -43.2% |
| 2024 | $44.0K | +46.7% |
| 2023 | $30.0K | -85.8% |
| 2022 | $212.0K | -86.5% |
| 2021 | $1.57M | +1379.2% |
| 2020 | $106.0K | -77.3% |
| 2019 | $466.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $25.0K | -43.2% |
| 2024 | $44.0K | +46.7% |
| 2023 | $30.0K | -85.8% |
| 2022 | $212.0K | -86.5% |
| 2021 | $1.57M | +1379.2% |
| 2020 | $106.0K | -77.3% |
| 2019 | $466.0K | — |